Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers

Bibliography

• Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 1991;174(1):139-49
   PubMed Web of Science ®Google Scholar
• Jakel CE, Hauser S, Rogenhofer S, et al. Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma. Clin Dev Immunol 2012;2012:473245
   PubMedGoogle Scholar
• Jiang J, Wu C, Lu B. Cytokine-induced killer cells promote antitumor immunity. J Transl Med 2013;11:83
   Google Scholar
• Wang Y, Dai H, Li H, et al. Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells. Clin Dev Immunol 2011;2011:621414
   PubMedGoogle Scholar
• Liu L, Zhang W, Qi X, et al. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma. Clin Cancer Res 2012;18(6):1751-9
   PubMed Web of Science ®Google Scholar
• Laport GG, Sheehan K, Baker J, et al. Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011;17(11):1679-87
   PubMed Web of Science ®Google Scholar
• Rutella S, Iudicone P, Bonanno G, et al. Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol. Cytotherapy 2012;14(7):841-50
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Minami T, Nozawa M, et al. Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma. Br J Cancer 2013;108(6):1260-6
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang W, Qi X, et al. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma. Clin Cancer Res 2012;18(6):1751-9
   PubMed Web of Science ®Google Scholar
• Higano CS, Schellhammer PF, Small EJ, et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 2009;115(16):3670-9
   PubMed Web of Science ®Google Scholar
• Clark JI, Atkins MB, Urba WJ, et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol 2003;21(16):3133-40
   PubMed Web of Science ®Google Scholar
• Shi L, Zhou Q, Wu J, et al. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother 2012;61(12):2251-9
   PubMed Web of Science ®Google Scholar
• Hontscha C, Borck Y, Zhou H, et al. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 2011;137(2):305-10
   PubMed Web of Science ®Google Scholar
• Wang Y, Bo J, Dai HR, et al. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo. Exp Hematol 2013;41(3):241-52.e3
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Wang Y, et al. Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy. Clin Dev Immunol 2013;2013:195691
   PubMedGoogle Scholar
• Burger SR. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003;5(4):289-98
   PubMed Web of Science ®Google Scholar
• Cruz CR, Hanley PJ, Liu H, et al. Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience. Cytotherapy 2010;12(6):743-9
   PubMed Web of Science ®Google Scholar
• Proposed approach to regulation of cellular and tissue-based products. The Food and Drug Administration. J Hematother 1997;6(3):195-212
   PubMedGoogle Scholar
• Wing M. Monoclonal antibody first dose cytokine release syndromes-mechanisms and prediction. J Immunotoxicol 2008;5(1):11-15
   PubMed Web of Science ®Google Scholar
• Beatty GL, Torigian DA, Chiorean EG, et al. A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma. Clin Cancer Res 2013;19(22):6286-95
   PubMed Web of Science ®Google Scholar
• Verneris MR, Baker J, Edinger M, et al. Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice. J Clin Immunol 2002;22(3):131-6
   PubMed Web of Science ®Google Scholar
• Edinger M, Cao YA, Verneris MR, et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003;101(2):640-8
   PubMed Web of Science ®Google Scholar
• Marin V, Dander E, Biagi E, et al. Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy. Exp Hematol 2006;34(9):1219-29
   PubMed Web of Science ®Google Scholar
• Hoyle C, Bangs CD, Chang P, et al. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood 1998;92(9):3318-27
   PubMed Web of Science ®Google Scholar
• Thorne SH, Contag CH. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Gene Ther 2008;10):753-8
   PubMed Web of Science ®Google Scholar
• Martin T, Duffy SF, Carson DA, et al. Evidence for somatic selection of natural autoantibodies. J Exp Med 1992;175(4):983-91
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 1996;87(7):2615-20
   PubMed Web of Science ®Google Scholar
• Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science 2003;301(5638):1374-7
   PubMed Web of Science ®Google Scholar